At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
fesoterodine +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Single-Dose, Randomized, Cross-Over Study To Estimate The Bioavailability And Food Effect Of 4 Mg Fesoterodine Extended Release Beads-In-Capsule Formulations Compared To Commercial Tablet Formulation In Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating fesoterodine for Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedJan 2011
Primary CompletionMar 2011
TodayJul 2026
First PostedJan 31, 2011
Enrollment StartDec 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.4 years ago
Interventions
fesoterodinedrug
single dose of beads in capsule
fesoterodinedrug
single dose of beads in capsule
fesoterodinedrug
single dose of beads in capsule
fesoterodinedrug
single dose of beads in capsule
fesoterodinedrug
single dose of tablet
fesoterodinedrug
single dose of beads in capsule